Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EBIT Growth

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 229.27-86.50-2.11181.6027.46

What is the latest EBIT Growth ratio of SAMRAT PHARMACHEM ?

The latest EBIT Growth ratio of SAMRAT PHARMACHEM is 229.27 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025229.27
Mar2024-86.50
Mar2023-2.11
Mar2022181.60
Mar202127.46

How is EBIT Growth of SAMRAT PHARMACHEM Trending?

Years EBIT Growth % Change
Mar2025 229.27
Positive
Mar2024 -86.5
Negative
Mar2023 -2.11
Negative
Mar2022 181.6
561.33
Mar2021 27.46 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EBIT Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹62.6 Cr -6.5% -4.7% -40.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-6.5%

-4.7%

-40.6%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses